Efficacy and safety of dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sufonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
If brand GLP-1 prices rise due to tariff pass-through, compounded alternatives become even more competitive
Evidence indicates that myricetin plant possesses anti-diabetic properties, which are mediated through the regulation of glucose transport via glucose transporter
Figure 2 Table 1 Characteristics of cross-sectional studies evaluating herbal medicine use during pregnancy in sub-Saharan Africa
[DOI] [PubMed] [Google Scholar] Evans P
Patients who require escalating laxative doses or find that previously effective treatments no longer work should discuss alternative management strategies with their provider